BioCentury
ARTICLE | Clinical News

AT7519: Phase II started

August 23, 2010 7:00 AM UTC

Astex began an open-label, U.S. Phase II trial to evaluate intravenous AT7519 alone or with Velcade bortezomib in up to 30 patients. Millennium Pharmaceuticals Inc., a subsidiary of Takeda Pharmace...